These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11557168)

  • 1. Human response to repeated low-dose d-amphetamine: evidence for behavioral enhancement and tolerance.
    Strakowski SM; Sax KW; Rosenberg HL; DelBello MP; Adler CM
    Neuropsychopharmacology; 2001 Oct; 25(4):548-54. PubMed ID: 11557168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.
    Brauer LH; de Wit H
    Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of a new central adrenergic agonist--modafinil--and D-amphetamine on sleep and early morning behaviour in young healthy volunteers.
    Saletu B; Frey R; Krupka M; Anderer P; Grünberger J; Barbanoj MJ
    Int J Clin Pharmacol Res; 1989; 9(3):183-95. PubMed ID: 2568348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute doses of d-amphetamine and bupropion increase cigarette smoking.
    Cousins MS; Stamat HM; de Wit H
    Psychopharmacology (Berl); 2001 Sep; 157(3):243-53. PubMed ID: 11605079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans.
    Strakowski SM; Sax KW; Setters MJ; Keck PE
    Biol Psychiatry; 1996 Nov; 40(9):872-80. PubMed ID: 8896773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects of d-amphetamine in humans: influence of subclinical levels of inattention and hyperactivity.
    Sevak RJ; Stoops WW; Rush CR
    Am J Drug Alcohol Abuse; 2010 Jul; 36(4):220-7. PubMed ID: 20560842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an acute d-amphetamine administration on context information memory in healthy volunteers: evidence from a source memory task.
    Zeeuws I; Deroost N; Soetens E
    Hum Psychopharmacol; 2010; 25(4):326-34. PubMed ID: 20521323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.
    Rush CR; Stoops WW; Hays LR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):261-71. PubMed ID: 18926645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of d-amphetamine on post-error slowing in healthy volunteers.
    Wardle MC; Yang A; de Wit H
    Psychopharmacology (Berl); 2012 Mar; 220(1):109-15. PubMed ID: 21894485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain potential indices of novelty processing are associated with preference for amphetamine.
    Gabbay FH; Duncan CC; McDonald CG
    Exp Clin Psychopharmacol; 2010 Dec; 18(6):470-88. PubMed ID: 21186922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in auditory selective attention and event-related potentials following oral administration of D-amphetamine in humans.
    McKetin R; Ward PB; Catts SV; Mattick RP; Bell JR
    Neuropsychopharmacology; 1999 Sep; 21(3):380-90. PubMed ID: 10457535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of amphetamine on reactivity to emotional stimuli.
    Wardle MC; de Wit H
    Psychopharmacology (Berl); 2012 Mar; 220(1):143-53. PubMed ID: 21947316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine.
    Veenstra-VanderWeele J; Qaadir A; Palmer AA; Cook EH; de Wit H
    Neuropsychopharmacology; 2006 May; 31(5):1056-63. PubMed ID: 16237383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contextual conditioning enhances the psychostimulant and incentive properties of d-amphetamine in humans.
    Childs E; de Wit H
    Addict Biol; 2013 Nov; 18(6):985-92. PubMed ID: 22129527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personality and the acute subjective effects of d-amphetamine in humans.
    Kirkpatrick MG; Johanson CE; de Wit H
    J Psychopharmacol; 2013 Mar; 27(3):256-64. PubMed ID: 23343596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans.
    Stoops WW; Glaser PE; Fillmore MT; Rush CR
    J Psychopharmacol; 2004 Dec; 18(4):534-43. PubMed ID: 15582920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers.
    Jasinski DR; Krishnan S
    J Psychopharmacol; 2009 Jun; 23(4):410-8. PubMed ID: 18635707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress-induced changes in mood and cortisol release predict mood effects of amphetamine.
    Hamidovic A; Childs E; Conrad M; King A; de Wit H
    Drug Alcohol Depend; 2010 Jun; 109(1-3):175-80. PubMed ID: 20176450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.